GE HealthCare's $945M Purchase of SOFIE Biosciences Aims to Strengthen Final Mile Manufacturing, Distribution

GE HealthCare announced a $945 million acquisition of SOFIE Biosciences to enhance its final mile manufacturing and distribution capabilities. This strategic purchase strengthens GE HealthCare's position in medical device manufacturing and logistics.